A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
NCT00038714
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Papilloma
Recurrent Respiratory Papillomatosis
Interventions
DRUG:
SGN-00101
Sponsor
Nventa Biopharmaceuticals Corporation